| Ticker Details |
|
Nuvalent, Inc.
|
| IPO Date: |
July 29, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$7.8B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.30 | 2.93%
|
| Avg Daily Range (30 D): |
$2.35 | 2.26%
|
| Avg Daily Range (90 D): |
$2.26 | 2.26%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.43M |
| Avg Daily Volume (90 D): |
.48M |
| Trade Size |
| Avg Trade Size (Sh.): |
48 |
| Avg Trade Size (Sh.) (30 D): |
45 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Institutional Trades: |
2,045 |
| Avg Institutional Trade: |
$3.29M |
| Avg Institutional Trade (30 D): |
$4.4M |
| Avg Institutional Trade (90 D): |
$5.3M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.09M |
| Avg Closing Trade (30 D): |
$6.51M |
| Avg Closing Trade (90 D): |
$8.47M |
| Avg Closing Volume: |
72.75K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-5.33
|
$-1.7
|
$-1.39
|
|
Diluted EPS
|
$-5.33
|
$-1.7
|
$-1.39
|
|
Revenue
|
$-25.3M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-381.44M
|
$-122.44M
|
$-99.65M
|
|
Operating Income / Loss
|
$-398.38M
|
$-112.7M
|
$-104.57M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-253.49M
|
$-11.72M
|
$6.64M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Mar 10, 2017
|
1:1200000
|
|
|
|